Amin A, Stemkowski S, Lin J, Yang G
School of Medicine, University of California-Irvine, Irvine, CA, USA.
J Thromb Haemost. 2007 Aug;5(8):1610-6. doi: 10.1111/j.1538-7836.2007.02650.x.
As hospitalized medical patients may be at risk of venous thromboembolism (VTE), evidence-based guidelines are available to help physicians assess patients' risk for VTE, and to recommend prophylaxis options. The rate of appropriate thromboprophylaxis use in at-risk medical inpatients was assessed in accordance with the 6th American College of Chest Physicians (ACCP) guidelines.
Hospital discharge information from the Premier Perspective(trade mark) inpatient data base from January 2002 to September 2005 was used. Included patients were 40 years old or more, with a length of hospital stay of 6 days or more, and had no contraindications for anticoagulation. The appropriateness of VTE thromboprophylaxis was determined in seven groups with acute medical conditions by comparing the daily thromboprophylaxis usage, including type of thromboprophylaxis, dosage of anticoagulant and duration of thromboprophylaxis, with the ACCP recommendations.
A total of 196 104 discharges from 227 hospitals met the inclusion criteria. The overall VTE thromboprophylaxis rate was 61.8%, although the appropriate thromboprophylaxis rate was only 33.9%. Of the 66.1% discharged patients who did not receive appropriate thromboprophylaxis, 38.4% received no prophylaxis, 4.7% received mechanical prophylaxis only, 6.3% received an inappropriate dosage, and 16.7% received an inappropriate prophylaxis duration based on ACCP recommendations.
This study highlights the low rates of appropriate thromboprophylaxis in US acute-care hospitals, with two-thirds of discharged patients not receiving prophylaxis in accordance with the 6th ACCP guidelines. More effort is required to improve the use of appropriate thromboprophylaxis in accordance with the ACCP recommendations.
由于住院的内科患者可能存在静脉血栓栓塞(VTE)风险,现有循证指南可帮助医生评估患者的VTE风险,并推荐预防措施。根据美国胸科医师学会(ACCP)第6版指南对有风险的内科住院患者进行适当的血栓预防用药率评估。
使用2002年1月至2005年9月Premier Perspective(商标)住院数据库中的医院出院信息。纳入患者年龄在40岁及以上,住院时间为6天及以上,且无抗凝治疗禁忌症。通过比较每日血栓预防用药情况,包括血栓预防类型、抗凝剂剂量和血栓预防持续时间,与ACCP建议,确定七组患有急性内科疾病患者的VTE血栓预防是否恰当。
227家医院共有196104例出院患者符合纳入标准。VTE血栓预防的总体使用率为61.8%,但适当的血栓预防率仅为33.9%。在未接受适当血栓预防的66.1%出院患者中,38.4%未接受任何预防措施,4.7%仅接受机械预防措施,6.3%接受了不适当的剂量,16.7%接受了不符合ACCP建议的不适当预防持续时间。
本研究凸显了美国急症医院适当血栓预防率较低,三分之二的出院患者未按照ACCP第6版指南接受预防措施。需要做出更多努力,以提高按照ACCP建议使用适当血栓预防措施的比例。